Point72 Asia (Singapore) Pte. Ltd. Applied Therapeutics Inc. Call Options Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
100Shares Held
94MCall Options Held
5.83MPut Options Held
231K-
Franklin Resources Inc San Mateo, CA10.6MShares$46.3 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.08MShares$39.7 Million5.3% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$35.1 Million1.14% of portfolio
-
Janus Henderson Group PLC London, X06.41MShares$28.1 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA6.11MShares$26.8 Million24.19% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $210M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...